Last reviewed · How we verify

NCT07037069

Effectiveness of DT vs GMIT on Wrist Pain and Function in Patients With Reflex Sympathetic Dystrophy

Active, enrolled NA Last updated 25 June 2025
What this trial tests

NA trial testing Desensitization Training in Sympathetic; Dystrophy in 40 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
4 March 2025
Primary endpoint
1 June 2025
30 September 2025

Quick facts

Lead sponsorSuperior University
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposehealth services research
Enrollment40
Start date4 March 2025
Primary completion1 June 2025
Estimated completion30 September 2025
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Superior University

Who can join

Adults 18 to 65, any sex, with Sympathetic; Dystrophy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluated the effectiveness of two therapeutic approaches-Desensitization Training (DT) and Graded Motor Imagery (GMI)-in reducing wrist pain and improving function in patients with Reflex Sympathetic Dystrophy (RSD). The sample size was calculated using Epitools for one-way ANOVA comparison with two independent groups. A total of 40 participants were randomly assigned into two groups: the DT group and the GMI group, each consisting of 20 patients. The DT group underwent sessions involving progressive tactile stimulation using different textures and temperatures to reduce hypersensitivity and allodynia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Superior University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07037069.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing